PACB Stock Analysis: Buy, Sell, or Hold?
PACB - Pacific Biosciences of California, Inc.
$1.49
-0.07 (-4.49%)
▼
5d:
-10.24%
30d:
+8.76%
90d:
+11.19%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When PACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called PACB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PACB is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PACB is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PACB is currently trading at $1.49, which is considered fair relative to its 30-day fair value range of $1.35 to $1.64.
Technical Outlook: Technically, PACB is in a downtrend. Immediate support is located at $1.25, while resistance sits at $1.77. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.46 (+65.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PACB is in a downtrend. Immediate support is located at $1.25, while resistance sits at $1.77. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.46 (+65.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.35 -
$1.64
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
Holding PACB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.5%)
- BULLISH: Trading 65.0% below Wall St target ($2.46)
- WARNING: Recommendation downgraded due to -10.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.35 -
$1.64
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.25
Resistance Level
$1.77
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.76
Wall Street Target
$2.46
(+65.0%)
Revenue Growth (YoY)
0.1%
Profit Margin
-80.3%
Share & Embed Analysis
Last updated: July 14, 2026 7:03 AM ET
Data refreshes hourly during market hours. Next update: 8:03 AM
Data refreshes hourly during market hours. Next update: 8:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Christian O Henry
SELL
12497 shares
2026-03-03
Michele Farmer
SELL
2979 shares
2026-03-03
Oene Mark Van
SELL
6504 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 62 BUY |
Advanced PACB Option Strategies
Professional options setups generated by AI based on today's PACB price and gamma walls.
